Your browser doesn't support javascript.
loading
Toxicity and tolerability of recombinant human ciliary neurotrophic factor in patients with amyotrophic lateral sclerosis.
Miller, R G; Bryan, W W; Dietz, M A; Munsat, T L; Petajan, J H; Smith, S A; Goodpasture, J C.
Affiliation
  • Miller RG; Department of Neurology, California Pacific Medical Center, San Francisco, USA.
Neurology ; 47(5): 1329-31, 1996 Nov.
Article in En | MEDLINE | ID: mdl-8909453
ABSTRACT
We examined the toxicity of both single and multiple subcutaneous injections of recombinant human ciliary neurotrophic factor (rhCNTF) in 72 patients with ALS, in doses ranging from 2 to 100 micrograms/kg. Adverse events were generally dose related and ranged from mild to severe. The tolerability of daily subcutaneous rhCNTF was equivalent to placebo at doses < or = 5 micrograms/kg/day. At higher doses, anorexia, weight loss, reactivation of herpes simplex virus (HSV1) labialis/stomatitis, cough, and increased oral secretions occurred.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Amyotrophic Lateral Sclerosis / Nerve Growth Factors / Nerve Tissue Proteins Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: Neurology Year: 1996 Document type: Article Affiliation country: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Amyotrophic Lateral Sclerosis / Nerve Growth Factors / Nerve Tissue Proteins Type of study: Clinical_trials Limits: Adult / Female / Humans / Male Language: En Journal: Neurology Year: 1996 Document type: Article Affiliation country: United States